Friday, 11 September 2020
The COVID-19 pandemic, Brexit, U.S. tariffs, and other developments have led to supply chain vulnerabilities and disruptions for some organisations over the past six months, costing hundreds of millions of pounds in industries including pharmaceuticals, consumer goods, luxury, electronics and automotive. This disruption is likely to continue, in particular for Franco-British businesses as the end of the UK transition period gets closer. Aline Doussin, partner at Hogan Lovells, Christian Fatras, economic counsellor at the French Embassy in the UK, and Benham Heidari, head of supply chain at Sanofi, discuss the risks from a political, legal and business angle. Watch the webinar and view the slides here.
- The Hogan Lovells Government Relations and Public Affairs group is tracking all of the latest developments in the U.S. Congress and relevant news stories. The Senate failed Thursday to get the 60 votes needed on a procedural step need to advance the Republican “skinny” coronavirus relief bill toward passage. As hopes of reaching a deal on legislation diminish, the White House is discussing unilateral executive actions to direct funding to some of the industries that continue to struggle in economic recovery. Meanwhile, President Trump and the White House continue to do damage control from the release of the tapes and excerpts of Bob Woodward’s new book claiming that the president knew the coronavirus was “deadly” even as he was publicly downplaying it. The Trump administration is rolling back the limitations it placed on where international flights can land and the requirement for enhanced medical screening for incoming international flights next week. According to a CDC study, more than 40 percent of U.S. adults said they have delayed or avoided medical care during the coronavirus pandemic and about 12 percent avoided emergency medical care. Read about these and other updates online here. (Authored by Ivan Zapien)
Wednesday, 9 September 2020
The National Academies of Sciences, Engineering, and Medicine (NASEM) has released in draft form a report providing recommendations on how to prioritize access to a COVID-19 vaccine, once one is available. The National Academies are preparing the report, called a “consensus study,” at the request of the National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC). The draft report is an initial step toward developing federal policy for vaccine distribution and is intended to inform policymakers. The draft report does not set federal policy, but does provide insight food companies may find valuable in planning their COVID-19 management strategies into 2021. The draft report is available for a brief, four-day public comment period, closing Friday, 4 September. Read more here. (Authored by Elizabeth Fawell)
On 27 August 2020, the U.S. Department of Labor (DOL) issued guidance (in FAQs numbered 98-100) clarifying how the childcare provisions of the Family First Coronavirus Response Act (FFCRA) apply to various remote and in-person school situations. The FFCRA generally requires private employers with fewer than 500 employees and many public sector employers to provide paid leave to eligible employees for certain COVID-19 related reasons, including up to 12 weeks of partially paid leave because of the employee’s need to care for a child whose school or place of care is closed, or whose child care provider is unavailable, due to COVID-19. Employees qualifying for this FFCRA childcare leave are entitled to two-thirds of their regular pay, up to $200 per day and $12,000 in the aggregate, for which private employers can claim a fully refundable tax credit. Read more here. (Authored by George W. Ingham)
Ivan Zapien, partner and practice leader of the U.S. Government Relations and Public Affairs practice, focuses his podcast on the issues, people, and culture that help shape Washington, D.C. In the latest episode, Ivan chats with Lillian Hardy, partner at Hogan Lovells, and Matthew Miller, partner at Vianovo, about how to manage a crisis in a pandemic, and communicating in the COVID-era.
New Rules for consideration of oppositions and related IP cases by the Russian Patent and Trademark Office (Rospatent) enter into force on 6 September 2020 replacing Rospatent’s rules of 2003. The Rules provide for electronic filing and case management on the Rospatent website. The Rules broaden the scope of challenge of the tribunal’s members extending it to any situations where the member may be directly or indirectly interested in the outcome of the case or where there is evidence of lack of tribunal member’s impartiality. The Head of Rospatent Mr. Grigory Ivliev noted that by virtue of the new rules the terms for consideration of disputes will be significantly reduced and electronic interaction with the parties will facilitate the work of Rospatent and reduce the COVID-19 related risks. Read more here. (Authored by Vironika Pilyugina)
Compiled by Aaron Armstrong